Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells

BACKGROUND: Despite rapid developments in immunotherapy and targeted therapy, dacarbazine (DTIC)-based chemotherapy still has been placed at the first-line for advanced melanoma patients who are after failure of immunotherapy or targeted therapy. However, the limited response rate and survival benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Junxia, Su, Zhou, Zeng, Xin, Zhong, Ya, Zhang, Yamei, Yang, Yixi, Lu, Qiuxia, Li, Jian, Deng, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077623/
https://www.ncbi.nlm.nih.gov/pubmed/37024907
http://dx.doi.org/10.1186/s12906-023-03933-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077623/
https://www.ncbi.nlm.nih.gov/pubmed/37024907
http://dx.doi.org/10.1186/s12906-023-03933-w

Ejemplares similares